BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Amin MA, El Gendy MM, Dawoud IE, Shoma A, Negm AM, Amer TA. Partial Splenic Embolization Versus Splenectomy for the Management of Hypersplenism in Cirrhotic Patients. World J Surg 2009;33:1702-10. [DOI: 10.1007/s00268-009-0095-2] [Cited by in Crossref: 51] [Cited by in F6Publishing: 40] [Article Influence: 4.3] [Reference Citation Analysis]
Number Citing Articles
1 Martins GLP, Bernardes JPG, Rovella MS, Andrade RG, Viana PCC, Herman P, Cerri GG, Menezes MR. Radiofrequency ablation for treatment of hypersplenism: A feasible therapeutic option. World J Gastroenterol 2015; 21(20): 6391-6397 [PMID: 26034376 DOI: 10.3748/wjg.v21.i20.6391] [Cited by in CrossRef: 1] [Article Influence: 0.2] [Reference Citation Analysis]
2 Jiang X, Gao F, Ma Y, Feng S, Liu X, Zhou H. Percutaneous Microwave Ablation in the Spleen for Treatment of Hypersplenism in Cirrhosis Patients. Dig Dis Sci. 2016;61:287-292. [PMID: 26031423 DOI: 10.1007/s10620-015-3732-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
3 Tremblay D, Schwartz M, Bakst R, Patel R, Schiano T, Kremyanskaya M, Hoffman R, Mascarenhas J. Modern management of splenomegaly in patients with myelofibrosis. Ann Hematol 2020;99:1441-51. [PMID: 32417942 DOI: 10.1007/s00277-020-04069-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
4 Shi B, Zhu H, Liu Y, Lü L, Jin C, Ran L, Zhou K, Yang W, Wang Z, Mei Z. Experimental Studies and Clinical Experiences on Treatment of Secondary Hypersplenism with Extracorporeal High-Intensity Focused Ultrasound. Ultrasound in Medicine & Biology 2012;38:1911-7. [DOI: 10.1016/j.ultrasmedbio.2012.07.010] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
5 DuBois B, Mobley D, Chick JFB, Srinivasa RN, Wilcox C, Weintraub J. Efficacy and safety of partial splenic embolization for hypersplenism in pre- and post-liver transplant patients: A 16-year comparative analysis. Clin Imaging. 2019;54:71-77. [PMID: 30553121 DOI: 10.1016/j.clinimag.2018.11.012] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
6 Kim H, Suh KS, Jeon YM, Park MS, Choi Y, Mori S, Hong G, Lee HW, Yi NJ, Lee KW. Partial splenic artery embolization for thrombocytopenia and uncontrolled massive ascites after liver transplantation. Transplant Proc. 2012;44:755-756. [PMID: 22483487 DOI: 10.1016/j.transproceed.2012.01.066] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
7 Li Y, Liu Z, Liu C. Efficacy and safety of laparoscopic splenectomy for hypersplenism secondary to portal hypertension after transjugular intrahepatic portosystemic shunt. BMC Gastroenterol 2021;21:61. [PMID: 33573590 DOI: 10.1186/s12876-021-01647-2] [Reference Citation Analysis]
8 Wang Y, Zhang J, Zhang F, Zhao Y, Gong J. Partial Splenic Artery Embolization to Treat Hypersplenism Secondary to Hepatic Cirrhosis: A Meta-Analysis. The American Surgeon 2017;83:274-83. [DOI: 10.1177/000313481708300323] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
9 Zhang XY, Li C, Wen TF, Yan LN, Li B, Yang JY, Wang WT, Jiang L. Synchronous splenectomy and hepatectomy for patients with hepatocellular carcinoma and hypersplenism: A case-control study. World J Gastroenterol 2015; 21(8): 2358-2366 [PMID: 25741142 DOI: 10.3748/wjg.v21.i8.2358] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 21] [Article Influence: 3.2] [Reference Citation Analysis]
10 Hadduck TA, McWilliams JP. Partial splenic artery embolization in cirrhotic patients. World J Radiol 2014; 6(5): 160-168 [PMID: 24876920 DOI: 10.4329/wjr.v6.i5.160] [Cited by in CrossRef: 41] [Cited by in F6Publishing: 29] [Article Influence: 5.9] [Reference Citation Analysis]
11 Cai M, Huang W, Lin C, Li Z, Qian J, Huang M, Zeng Z, Huang J, Shan H, Zhu K. Partial splenic embolization for thrombocytopenia in liver cirrhosis: predictive factors for platelet increment and risk factors for major complications. Eur Radiol 2016;26:370-80. [DOI: 10.1007/s00330-015-3839-4] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
12 Kim NH, Kim HJ, Cho YK, Hong HP, Kim BI. Long-Term Efficacy and Safety of Partial Splenic Embolization in Hepatocellular Carcinoma Patients with Thrombocytopenia Who Underwent Transarterial Chemoembolization. J Korean Med Sci 2019;34:e208. [PMID: 31373186 DOI: 10.3346/jkms.2019.34.e208] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
13 Zaitoun MMA, Basha MAA, Elsayed SB, El Deen DS, Zaitoun NA, Alturkistani H, Farag AA, Abdelsalam H, El-Kenawy HA, Mahmoud NEM, Alayouty NA, Eladl IM, Shahin S, Almarzooqi MK, Hendi AM, El-Morsy A, Elmokadem AH. Comparison of three embolic materials at partial splenic artery embolization for hypersplenism: clinical, laboratory, and radiological outcomes. Insights Imaging 2021;12:85. [PMID: 34173891 DOI: 10.1186/s13244-021-01030-5] [Reference Citation Analysis]
14 Tahara H, Takagi H, Sato K, Shimada Y, Tojima H, Hirokawa T, Ohyama T, Horiuchi K, Naganuma A, Arai H. A retrospective cohort study of partial splenic embolization for antiviral therapy in chronic hepatitis C with thrombocytopenia. J Gastroenterol. 2011;46:1010-1019. [PMID: 21594564 DOI: 10.1007/s00535-011-0407-9] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
15 Makino T, Zhou J, Pankaj P, Peng B. Comparative treatment and literature review for laparoscopic splenectomy alone versus preoperative splenic artery embolization splenectomy. Surg Endosc. 2012;2758-2766. [PMID: 22580870 DOI: 10.1007/s00464-012-2270-z] [Cited by in Crossref: 29] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
16 Wu T, Sun R, Huang Y, Wang Z, He J, Shen S, Yin X, Zhu Z, Yang W, Zhao Z. Partial splenic embolization of patients with hypersplenism by transradial or transfemoral approach: a prospective randomized controlled trial. Acta Radiol 2016;57:1201-4. [DOI: 10.1177/0284185115622076] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
17 Zhang L, Zhang ZG, Long X, Liu FL, Zhang WG. Severe Complications After Splenic Artery Embolization for Portal Hypertension Due to Hepatic Cirrhosis. Risk Manag Healthc Policy 2020;13:135-40. [PMID: 32110126 DOI: 10.2147/RMHP.S234628] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
18 Gangireddy VG, Kanneganti PC, Sridhar S, Talla S, Coleman T. Management of thrombocytopenia in advanced liver disease. Can J Gastroenterol Hepatol. 2014;28:558-564. [PMID: 25222481 DOI: 10.1155/2014/532191] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.7] [Reference Citation Analysis]
19 Moon E, Tam MD, Kikano RN, Karuppasamy K. Prophylactic antibiotic guidelines in modern interventional radiology practice. Semin Intervent Radiol 2010;27:327-37. [PMID: 22550374 DOI: 10.1055/s-0030-1267853] [Cited by in Crossref: 29] [Cited by in F6Publishing: 15] [Article Influence: 3.2] [Reference Citation Analysis]
20 Boyer TD, Habib S. Big spleens and hypersplenism: fix it or forget it? Liver Int. 2015;35:1492-1498. [PMID: 25312770 DOI: 10.1111/liv.12702] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 4.4] [Reference Citation Analysis]
21 Li W, Shen SQ, Wu SM, Chen ZB, Hu C, Yan RC. Simultaneous hepatectomy and splenectomy versus hepatectomy alone for hepatocellular carcinoma complicated by hypersplenism: a meta-analysis. Onco Targets Ther 2015;8:2129-37. [PMID: 26316782 DOI: 10.2147/OTT.S87580] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
22 Chai ZT, Zhang XP, Shao M, Ao JY, Chen ZH, Zhang F, Hu YR, Zhong CQ, Lin JH, Fang KP, Wu MC, Lau WY, Cheng SQ. Impact of splenomegaly and splenectomy on prognosis in hepatocellular carcinoma with portal vein tumor thrombus treated with hepatectomy. Ann Transl Med 2021;9:247. [PMID: 33708874 DOI: 10.21037/atm-20-2229] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Petermann A, Chabrot P, Cassagnes L, Dumousset E, Alfidja A, Gageanu C, Ravel A, Abergel A, Boyer L. Hypersplenism due to portal hypertension: retrospective evaluation of 17 patients treated by splenic embolization. Diagn Interv Imaging. 2012;93:30-36. [PMID: 22277708 DOI: 10.1016/j.diii.2011.11.008] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
24 Zhang X, Li C, Wen T, Peng W, Yan L, Li B, Yang J, Wang W, Xu M, Zeng Y. Synchronous splenectomy and hepatectomy for patients with small hepatocellular carcinoma and pathological spleen: neutrophil to lymphocyte ratio changes can predict the prognosis. Oncotarget. 2017;8:46298-46311. [PMID: 28549349 DOI: 10.18632/oncotarget.17758] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
25 Elbedewy TA, Elsebaey MA, Elshweikh SA, Elashry H, Abd-Elsalam S. Predictors for eltrombopag response in patients with hepatitis C virus-associated thrombocytopenia. Ther Clin Risk Manag 2019;15:269-74. [PMID: 30804674 DOI: 10.2147/TCRM.S186106] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
26 Uehara H, Akahoshi T, Kawanaka H, Hashimoto N, Nagao Y, Tomikawa M, Taketomi A, Shirabe K, Hashizume M, Maehara Y. Endothelin-1 derived from spleen-activated Rho-kinase pathway in rats with secondary biliary cirrhosis. Hepatol Res 2012;42:1039-47. [PMID: 22594838 DOI: 10.1111/j.1872-034X.2012.01021.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 2] [Article Influence: 1.1] [Reference Citation Analysis]
27 Cai M, Zhu K, Huang W, Meng X, He K, Zhou B, Guo Y, Chen J, Shan H. Portal vein thrombosis after partial splenic embolization in liver cirrhosis: efficacy of anticoagulation and long-term follow-up. J Vasc Interv Radiol. 2013;24:1808-1816. [PMID: 24099787 DOI: 10.1016/j.jvir.2013.08.018] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 2.6] [Reference Citation Analysis]
28 Kobayashi K, Maruyama H, Kiyono S, Sekimoto T, Kondo T, Shimada T, Takahashi M, Okugawa H, Yokosuka O. Portal response related to shunt occlusion by balloon-occluded retrograde transvenous obliteration may determine the prognosis of cirrhosis. Hepatol Res 2016;46:1321-9. [PMID: 26931092 DOI: 10.1111/hepr.12690] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
29 Qi X, Bai M, Guo X, Fan D. Pharmacologic prophylaxis of portal venous system thrombosis after splenectomy: a meta-analysis. Gastroenterol Res Pract 2014;2014:292689. [PMID: 25243008 DOI: 10.1155/2014/292689] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
30 Patel A, Weintraub JL, Nowakowski FS, Kim E, Fischman AM, Ellozy SH, Faries PL, Vouyouka AG, Marin ML, Lookstein RA. Single-center experience with elective transcatheter coil embolization of splenic artery aneurysms: technique and midterm follow-up. J Vasc Interv Radiol. 2012;23:893-899. [PMID: 22579853 DOI: 10.1016/j.jvir.2012.03.009] [Cited by in Crossref: 36] [Cited by in F6Publishing: 27] [Article Influence: 4.0] [Reference Citation Analysis]
31 Gong C, Qin X, Yang J, Guo T. The Best Anticoagulation Strategy for Cirrhotic Patients who Underwent Splenectomy: A Network Meta-Analysis. Gastroenterol Res Pract 2017;2017:9216172. [PMID: 28676822 DOI: 10.1155/2017/9216172] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
32 Li L, Chen H, Bao Y, Yu Q, Yang W. Successful Treatment of Hypersplenism in Wilson's Disease by Partial Splenic Embolization. Journal of Investigative Surgery 2017;31:75-81. [DOI: 10.1080/08941939.2016.1278058] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
33 Wu Y, Li H, Zhang T, Bai Z, Xu X, Levi Sandri GB, Wang L, Qi X. Splanchnic Vein Thrombosis in Liver Cirrhosis After Splenectomy or Splenic Artery Embolization: A Systematic Review and Meta-Analysis. Adv Ther 2021;38:1904-30. [PMID: 33687650 DOI: 10.1007/s12325-021-01652-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
34 Huang Y, Ren D, Gao F, Ding Y, Cheng H, Huang X, Xu X. An updated meta-analysis of partial splenic embolization versus splenectomy in the treatment of hypersplenism due to cirrhosis. Minim Invasive Ther Allied Technol 2021;:1-12. [PMID: 34106805 DOI: 10.1080/13645706.2021.1933535] [Reference Citation Analysis]
35 Yamada S, Morine Y, Imura S, Ikemoto T, Arakawa Y, Iwahashi S, Saito Y, Yoshikawa M, Teraoku H, Shimada M. Liver regeneration after splenectomy in patients with liver cirrhosis: Liver volume after splenectomy. Hepatol Res 2016;46:443-9. [DOI: 10.1111/hepr.12573] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
36 Fukui H, Saito H, Ueno Y, Uto H, Obara K, Sakaida I, Shibuya A, Seike M, Nagoshi S, Segawa M, Tsubouchi H, Moriwaki H, Kato A, Hashimoto E, Michitaka K, Murawaki T, Sugano K, Watanabe M, Shimosegawa T. Evidence-based clinical practice guidelines for liver cirrhosis 2015. J Gastroenterol 2016;51:629-50. [PMID: 27246107 DOI: 10.1007/s00535-016-1216-y] [Cited by in Crossref: 181] [Cited by in F6Publishing: 160] [Article Influence: 36.2] [Reference Citation Analysis]
37 Nassef AA, Zakaria AA, Abd Elbary MS. Partial splenic artery embolization in portal hypertension patients with hypersplenism: Two interval-spaced sessions’ technique. The Egyptian Journal of Radiology and Nuclear Medicine 2013;44:531-7. [DOI: 10.1016/j.ejrnm.2013.04.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
38 Zhang JS, Li L, Li Q, Cheng W. Laparoscopic splenic vessels ligation as a treatment of hypersplenism and thrombocytopenia in children. Surg Endosc 2016;30:3916-21. [PMID: 26659241 DOI: 10.1007/s00464-015-4698-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
39 Talwar A, Gabr A, Riaz A, Desai K, Thornburg B, Mouli S, Lewandowski RJ, Salem R. Adverse Events Related to Partial Splenic Embolization for the Treatment of Hypersplenism: A Systematic Review. J Vasc Interv Radiol 2020; 31: 1118-1131. e6. [PMID: 32014400 DOI: 10.1016/j.jvir.2019.08.015] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
40 Hayashi H, Takamura H, Yamaguchi Y, Shoji Y, Nakagawara H, Tajima H, Onishi I, Kitagawa H, Tani T, Kayahara M, Ohta T. Recent role of Hassab's operation for cirrhotic patients: Combination with endoscopic procedure for varices. Asian Journal of Surgery 2012;35:57-61. [DOI: 10.1016/j.asjsur.2012.04.024] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]